Success Metrics

Clinical Success Rate
86.7%

Based on 13 completed trials

Completion Rate
87%(13/15)
Active Trials
5(23%)
Results Posted
31%(4 trials)
Terminated
2(9%)

Phase Distribution

Ph phase_1
5
23%
Ph phase_2
4
18%
Ph early_phase_1
2
9%
Ph phase_4
3
14%
Ph not_applicable
5
23%
Ph phase_3
3
14%

Phase Distribution

7

Early Stage

4

Mid Stage

6

Late Stage

Phase Distribution22 total trials
Early Phase 1First-in-human
2(9.1%)
Phase 1Safety & dosage
5(22.7%)
Phase 2Efficacy & side effects
4(18.2%)
Phase 3Large-scale testing
3(13.6%)
Phase 4Post-market surveillance
3(13.6%)
N/ANon-phased studies
5(22.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.3%

13 of 16 finished

Non-Completion Rate

18.8%

3 ended early

Currently Active

5

trials recruiting

Total Trials

22

all time

Status Distribution
Active(6)
Completed(13)
Terminated(3)

Detailed Status

Completed13
Active, not recruiting3
Recruiting2
Terminated2
Withdrawn1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
22
Active
5
Success Rate
86.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (9.1%)
Phase 15 (22.7%)
Phase 24 (18.2%)
Phase 33 (13.6%)
Phase 43 (13.6%)
N/A5 (22.7%)

Trials by Status

withdrawn15%
recruiting29%
terminated29%
not_yet_recruiting15%
active_not_recruiting314%
completed1359%

Recent Activity

Clinical Trials (22)

Showing 20 of 22 trialsScroll for more
NCT07472491Phase 2

A Phase 2/3 Study on the Efficacy and Safety of Mangaciclanol for Contrast-Enhanced MRI of CNS or Body in Adult Patients

Recruiting
NCT04893434Phase 1

Novel Imaging Technique to Assess Gynecologic Cancer

Active Not Recruiting
NCT03730051Phase 4

Dotarem vs Gadobutrol Contrast for Breast MRI

Completed
NCT04373564Phase 4

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

Recruiting
NCT05915728Phase 3

A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Any Known or Suspected Problems of the Body (Except Brain or Spinal Cord-related Problems)

Completed
NCT02156739Not Applicable

Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions

Active Not Recruiting
NCT04219904Early Phase 1

PET/MRI Scan for the Evaluation of Resectable Stage IA1-IB3 Cervical Cancer

Active Not Recruiting
NCT04910425Phase 2

PSMA-Targeted 18F-DCFPyL PET/MRI for the Detection of Prostate Cancer

Withdrawn
NCT06224543Phase 1

MR Image Synthesis With Low Gadobutrol Dose and AI

Completed
NCT05915702Phase 3

A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Known or Suspected Brain or Spinal Cord-related Problems

Completed
NCT05811377Early Phase 1

Phenotyping Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) by Intravesical Contrast Enhanced - Magnetic Resonance Imaging (ICE-MRI) Bladder Permeability Assay

Completed
NCT06731829Phase 2

A Study for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Brain and/or Spinal Cord Conditions

Not Yet Recruiting
NCT00375830Phase 2

Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases

Completed
NCT04132843Not Applicable

Novel MRI Techniques for the Characterization and Treatment Assessment of High Grade Brain Lesions

Completed
NCT03404648Phase 3

Staging Prostate Cancer With Hybrid C11-Choline PET/MR and mpMRI

Completed
NCT02135861Phase 1

A Method Validation Study for Evaluation of Novel Treatments Limiting Pulmonary Oedema in Cardiac Failure

Completed
NCT01989000Not Applicable

The Role of the Tumor Microenvironment of Pancreatic Cancer to Predict Treatment Outcome

Completed
NCT02350426Phase 1

A Study to Assess Inflammation in Rheumatoid Arthritis Using Molecular Imaging Techniques

Terminated
NCT02967380Not Applicable

Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases

Terminated
NCT01995240Not Applicable

Functional Magnetic Resonance Imaging of Pancreatic Cancer: a Feasibility and Reproducibility Study

Completed

Drug Details

Intervention Type
DRUG
Total Trials
22